User contributions for Kosar Doraghi
Jump to navigation
Jump to search
1 June 2024
- 03:2103:21, 1 June 2024 diff hist +15 Template:KDRG No edit summary current
- 03:2003:20, 1 June 2024 diff hist +16,566 N WINREVAIR Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D. [mailto:k.doraghi@yahoo.com] |genericName=sotatercept-csrk |aOrAn=an |drugClass=activin signaling inhibitor |indicationType=treatment |indication=adults with pulmonary arterial hypertension (PAH, WHO Group 1) to increase exercise capacity, improve WHO functional class (FC) and reduce the risk of clinical worsening events |hasBlackBoxWarning=Yes |adverseReactions=headache, epistaxis, rash, telangiect..." current
23 May 2024
- 02:0102:01, 23 May 2024 diff hist +18 Template:KDRG No edit summary
- 02:0002:00, 23 May 2024 diff hist +16,419 N Aprocitentan Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar.Doraghi, M.D.[mailto:k.doraghi@yahoo.com] |genericName=aprocitentan |aOrAn=an |drugClass=endothelin receptor antagonist |indicationType=treatment |indication=hypertension in combination with other antihypertensive drugs, to lower blood pressure in adult patients who are not adequately controlled on other drugs |hasBlackBoxWarning=Yes |adverseReactions=edema/fluid retention and anemia |blackBoxWarningTitle=W..." current
- 02:0002:00, 23 May 2024 diff hist −3 Template:KDRG No edit summary
- 01:4901:49, 23 May 2024 diff hist 0 N File:IMG 1225.jpeg No edit summary current
- 01:2801:28, 23 May 2024 diff hist 0 N File:IMG 1224.jpeg No edit summary current
- 01:2801:28, 23 May 2024 diff hist 0 N File:IMG 1223.jpeg No edit summary current
19 May 2024
- 03:5403:54, 19 May 2024 diff hist +1,728 Chronic obstructive pulmonary disease history and symptoms No edit summary current
14 May 2024
- 04:5504:55, 14 May 2024 diff hist +52 Somatrogon-ghla No edit summary current
12 May 2024
- 21:0621:06, 12 May 2024 diff hist +47 Template:KDRG No edit summary
- 21:0421:04, 12 May 2024 diff hist +215 Somatrogon-ghla No edit summary
- 20:5220:52, 12 May 2024 diff hist +13,854 Chronic renal failure overview No edit summary current
- 19:3519:35, 12 May 2024 diff hist 0 N File:IMG 1208.jpeg No edit summary current
- 19:3319:33, 12 May 2024 diff hist 0 N File:IMG 1207.jpeg No edit summary current
- 19:3219:32, 12 May 2024 diff hist 0 N File:IMG 1204.jpeg No edit summary current
- 19:3019:30, 12 May 2024 diff hist 0 N File:IMG 1202.jpeg No edit summary current
- 19:2819:28, 12 May 2024 diff hist 0 N File:IMG 1200.jpeg No edit summary current
- 19:2419:24, 12 May 2024 diff hist 0 N File:IMG 1214.jpeg No edit summary current
- 05:3005:30, 12 May 2024 diff hist +12,476 N Somatrogon-ghla Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D.[mailto:k.doraghi@yahoo.con] |genericName=somatrogon-ghla |aOrAn=a |drugClass=human growth hormone analog |indicationType=treatment |indication=pediatric patients aged 3 years and older who have growth failure due to inadequate secretion of endogenous growth hormone |hasBlackBoxWarning=Yes |adverseReactions=injection site reactions, nasopharyngitis, headache, pyrexia, anemia, cough, v..."
- 05:1505:15, 12 May 2024 diff hist 0 N File:IMG 1198.jpeg No edit summary current
- 05:1305:13, 12 May 2024 diff hist 0 N File:IMG 1215.jpeg No edit summary current
8 May 2024
- 21:3821:38, 8 May 2024 diff hist +174 Template:KDRG No edit summary
- 21:3821:38, 8 May 2024 diff hist +11 EXXUA No edit summary current
- 21:3221:32, 8 May 2024 diff hist +11,561 N EXXUA Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D.[mailto:k.doraghi@yahoo.com] |genericName=Gepirone |aOrAn=a |drugClass=extended-release tablets |indicationType=treatment |indication=major depressive disorder (MDD) in adults |hasBlackBoxWarning=Yes |adverseReactions=dizziness, nausea, insomnia, abdominal pain, and dyspepsia |blackBoxWarningTitle=WARNING: SUICIDAL THOUGHTS AND BEHAVIORS |blackBoxWarningBody=SEE FULL PRESCRIBING INFORMATION FOR..."
- 21:2721:27, 8 May 2024 diff hist 0 N File:IMG 1195.jpeg No edit summary current
- 21:2621:26, 8 May 2024 diff hist 0 N File:IMG 1196.jpeg No edit summary current
- 21:1921:19, 8 May 2024 diff hist 0 N File:IMG 1194.jpeg No edit summary current
3 May 2024
- 22:5722:57, 3 May 2024 diff hist +11,950 N Xacduro- sulbactam and durlobactam Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D. [mailto:k.doraghi@yahoo.com] |genericName=sulbactam and durlobactam |aOrAn=a |drugClass=co-packaged product containing sulbactam, a beta-lactam antibacterial and beta lactamase inhibitor, and durlobactam, a beta lactamase inhibitor, |indicationType=treatment |indication=hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP), caused by susceptible isolates of Acin..." current
1 May 2024
- 15:4615:46, 1 May 2024 diff hist +15,269 N Nirsevimab Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D. [mailto:k.doraghi@yahoo.com] |genericName=Nirsevimab |aOrAn=a |drugClass=respiratory syncytial virus (RSV) F protein‑directed fusion inhibitor |indicationType=prevention |indication=RSV lower respiratory tract disease in: Neonates and infants born during or entering their first RSV season, and children up to 24 months of age who remain vulnerable to severe RSV disease through their second RSV season |hasBlackBo..." current
- 15:3115:31, 1 May 2024 diff hist 0 N File:IMG 1185.jpeg No edit summary current
- 15:2915:29, 1 May 2024 diff hist 0 N File:IMG 1187.jpeg No edit summary current
27 April 2024
- 00:4900:49, 27 April 2024 diff hist +2,903 Chronic obstructive pulmonary disease history and symptoms No edit summary
24 April 2024
- 23:1723:17, 24 April 2024 diff hist +5,051 Endocarditis overview No edit summary current
- 23:0423:04, 24 April 2024 diff hist 0 N File:IMG 1177.jpeg No edit summary current
- 22:5922:59, 24 April 2024 diff hist 0 N File:IMG 1176.jpeg No edit summary current
21 April 2024
- 04:0304:03, 21 April 2024 diff hist +198 BRENZAVVY- bexagliflozin No edit summary current
- 03:4803:48, 21 April 2024 diff hist 0 N File:IMG 1052.jpeg No edit summary current
- 03:4703:47, 21 April 2024 diff hist +12,083 N BRENZAVVY- bexagliflozin Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D. [mailto:k.doraghi@yahoo.com] |genericName=BRENZAVVY- bexagliflozin |aOrAn=a |drugClass=sodium-glucose co-transporter 2 (SGLT2) inhibitor |indicationType=treatment |indication=glycemic control in adults with type 2 diabetes mellitus |hasBlackBoxWarning=Yes |adverseReactions=female genital mycotic infections, urinary tract infection and increased urination |blackBoxWarningTitle=Warnings |blackBoxWarningBody=*Not re..."
- 03:4303:43, 21 April 2024 diff hist 0 N File:IMG 1050.jpeg No edit summary current
- 03:4003:40, 21 April 2024 diff hist 0 N File:IMG 1051.jpeg No edit summary current
- 03:3403:34, 21 April 2024 diff hist 0 N File:IMG 1049.jpeg No edit summary current
19 April 2024
- 20:0320:03, 19 April 2024 diff hist +129 Template:KDRG No edit summary
- 19:5319:53, 19 April 2024 diff hist −69 Template:KDRG No edit summary
- 16:3016:30, 19 April 2024 diff hist +8,644 N Sparsentan Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi[mailto:k.doraghi@yahoo.com] |genericName=sparsentan |aOrAn=an |drugClass=endothelin and angiotensin II receptor antagonist |indicationType=treatment |indication=proteinuria(reduce) in adults with primary immunoglobulin A nephropathy (IgAN) at risk of rapid disease progression, generally a urine protein-to-creatinine ratio (UPCR) ≥1.5 g/g |hasBlackBoxWarning=Yes |adverseReactions=Hepatotoxicity, Embryo-Fetal Tox..." current
- 16:2416:24, 19 April 2024 diff hist 0 N File:IMG 1046.jpeg No edit summary current
- 16:1416:14, 19 April 2024 diff hist 0 N File:IMG 1045.jpeg No edit summary current
- 16:1116:11, 19 April 2024 diff hist 0 N File:IMG 1047.jpeg No edit summary current
- 16:0516:05, 19 April 2024 diff hist 0 N File:IMG 1044.jpeg No edit summary current
18 April 2024
- 06:1806:18, 18 April 2024 diff hist +2,588 Endocarditis overview No edit summary